ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Celebrating 20 Years
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Wichita study reveals much about who has Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS)

by Source: Healthwatch
January 1, 1999

In the opening session, Michele Reyes, PhD, an epidemiologist at the Centers for Disease Control and Prevention, made clear why the weekend was important.
“CFS in females in Wichita and in females in general is a much greater public health problem than previously believed,” Reyes said. In fact, CFS in women is about three times more prevalent than HIV and about one-third as prevalent as diabetes.
Overall, the CDC’s Wichita study, the most extensive and rigorous study of the prevalence of CFS to date, estimated that CFS affects 183 per 100,000 people between the ages of 18 and 69. That’s about 20 times the estimates from previous studies, which counted people who were diagnosed or people who sought medical treatment. In Wichita, few of the persons identified as having CFS had been diagnosed and most were not under the care of a physician.
The $1.7 million study involved calling more than 34,000 households representing more than 90,000 people, about a quarter of the population of Wichita and surrounding Sedgwick County. After detailed telephone interviews of all individuals who were fatigued for more than a month, those with CFS-like symptoms were evaluated in a clinic to determine whether they had CFS or another illness.
After a complex, weighted analysis of their data, the researchers estimated that out of every 1,000 adults, about 108 experience prolonged fatigue (lasting more than a month), 82 had chronic fatigue (more than six months), 16 had CFS-like symptoms, and just about 2 in 1,000 had CFS.
“This study indicates that CFS affects women and men of all racial and ethnic groups, as well as adolescents,” said Dr. William Reeves, chief of the CDC branch responsible for the study. “However, white women have the greatest risk for disease and this must be taken into account in planning allocation of health resources and searching for risk factors.”
Also, the numbers do not include anyone with any past or present melancholic depression. “We’re looking at the exclusion for melancholic depression much more closely now,” Reeves said. “Further understanding of these data will allow us to make recommendations about future case definitions.”
Wichita and Sedgwick County were chosen for the study because demographics there are similar to the entire United States.
The Wichita results were in line with preliminary data from another large population-based study being done at DePaul University in Chicago. Drs. Leonard Jason and Karen Jordan presented their early results on prolonged and chronic fatigue. That study also will include clinical evaluations of those with CFS-like illness to more reliably estimate actual CFS cases.
Dr. Jordan is studying CFS in children. So far in interviews with caregivers of nearly 4,000 children ages 5–17, she has found more than 2% or about 21 per 1,000 have CFS-like illness. That group is about equally split between boys and girls and about half are 12 or younger. Comprehensive medical and psychiatric evaluations will now be performed on those children to determine if they have CFS or another illness.

DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




Wichita study reveals much about who has Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Featured Vitamins, Supplements, and Health Products
Activated Nasal Mist by NOW Foods Activated Nasal Mist by NOW Foods
Relieves nasal irritation
Healthy Curb™ Healthy Curb™
Resets your appetite
Coenzyme Q10 50mg Coenzyme Q10 50mg
Top heart support & energy nutrient
Austin Air Allergy Machine Air Filter Austin Air Allergy Machine Air Filter
Removes 99.9% of all particles in up to 1,500 sq' of air
D-Ribose Powder by Now Foods D-Ribose Powder by Now Foods
Essential Nutrient for energy production
Most Viewed Articles & Abstracts
CFS Advisory Committee Meeting - Live Online Oct 29-30 [more]

Flu – What Is It That Stops Many People from Getting It? [more]

Body manufactures potent anti-inflammatory using DHA in fish oils - discovery holds much promise [more]

Intimacy - What to Do When ME/CFS or FM Becomes a Third Wheel in Your Relationship [more]

Dr. Charles Shepherd Updates His Advisory on Swine Flu & the Vaccine for ME/CFS Patients – A Highly ... [more]

ProHealth Vitamin and Supplement SmartSavings Club
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2009 ProHealth, Inc.